271 related articles for article (PubMed ID: 34263179)
1. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype.
Zhang B; Long Q; Wu S; Xu Q; Song S; Han L; Qian M; Ren X; Liu H; Jiang J; Guo J; Zhang X; Chang X; Fu Q; Lam EW; Campisi J; Kirkland JL; Sun Y
Nat Aging; 2021 May; 1(5):454-472. PubMed ID: 34263179
[TBL] [Abstract][Full Text] [Related]
2. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
4. Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment.
Miyata K; Zhou X; Nishio M; Hanyu A; Chiba M; Kawasaki H; Osako T; Takeuchi K; Ohno S; Ueno T; Maruyama R; Takahashi A
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2305046120. PubMed ID: 37523559
[TBL] [Abstract][Full Text] [Related]
5.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
6. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 antagonizes cellular senescence by remodeling chromatin accessibility at enhancer regions.
Zhang D; Zhu Y; Ju Y; Zhang H; Zou X; She S; Zhu D; Guan Y
Cell Mol Life Sci; 2023 Oct; 80(11):330. PubMed ID: 37856006
[TBL] [Abstract][Full Text] [Related]
8. Chromatin basis of the senescence-associated secretory phenotype.
Hao X; Wang C; Zhang R
Trends Cell Biol; 2022 Jun; 32(6):513-526. PubMed ID: 35012849
[TBL] [Abstract][Full Text] [Related]
9. HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci.
Aird KM; Iwasaki O; Kossenkov AV; Tanizawa H; Fatkhutdinov N; Bitler BG; Le L; Alicea G; Yang TL; Johnson FB; Noma KI; Zhang R
J Cell Biol; 2016 Nov; 215(3):325-334. PubMed ID: 27799366
[TBL] [Abstract][Full Text] [Related]
10. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
D'Ambrosio M; Gil J
Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
[TBL] [Abstract][Full Text] [Related]
11. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
[TBL] [Abstract][Full Text] [Related]
12. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
Chambers CR; Ritchie S; Pereira BA; Timpson P
Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
[TBL] [Abstract][Full Text] [Related]
13. Cellular senescence as a possible link between prostate diseases of the ageing male.
Fiard G; Stavrinides V; Chambers ES; Heavey S; Freeman A; Ball R; Akbar AN; Emberton M
Nat Rev Urol; 2021 Oct; 18(10):597-610. PubMed ID: 34294916
[TBL] [Abstract][Full Text] [Related]
14. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy.
Tarallo D; Martínez J; Leyva A; Mónaco A; Perroni C; Tassano M; Gambini JP; Cappetta M; Durán R; Moreno M; Quijano C
Sci Rep; 2024 Jan; 14(1):909. PubMed ID: 38195762
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice.
Shrestha N; Chaturvedi P; Zhu X; Dee MJ; George V; Janney C; Egan JO; Liu B; Foster M; Marsala L; Wong P; Cubitt CC; Foltz JA; Tran J; Schappe T; Hsiao K; Leclerc GM; You L; Echeverri C; Spanoudis C; Carvalho A; Kanakaraj L; Gilkes C; Encalada N; Kong L; Wang M; Fang B; Wang Z; Jiao JA; Muniz GJ; Jeng EK; Valdivieso N; Li L; Deth R; Berrien-Elliott MM; Fehniger TA; Rhode PR; Wong HC
Aging Cell; 2023 May; 22(5):e13806. PubMed ID: 36967480
[TBL] [Abstract][Full Text] [Related]
16. Pericentromeric repetitive ncRNA regulates chromatin interaction and inflammatory gene expression.
Miyata K; Takahashi A
Nucleus; 2022 Dec; 13(1):74-78. PubMed ID: 35167425
[TBL] [Abstract][Full Text] [Related]
17. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
18. Single-cell transcriptomics identifies senescence-associated secretory phenotype (SASP) features of testicular aging in human.
He J; Li J; Li Y; Xu Z; Ma M; Chen H; Chen P; Lv L; Shang X; Liu G
Aging (Albany NY); 2024 Feb; 16(4):3350-3362. PubMed ID: 38349859
[TBL] [Abstract][Full Text] [Related]
19. Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer.
Miyata K; Imai Y; Hori S; Nishio M; Loo TM; Okada R; Yang L; Nakadai T; Maruyama R; Fujii R; Ueda K; Jiang L; Zheng H; Toyokuni S; Sakata T; Shirahige K; Kojima R; Nakayama M; Oshima M; Nagayama S; Seimiya H; Hirota T; Saya H; Hara E; Takahashi A
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34426493
[TBL] [Abstract][Full Text] [Related]
20. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
